ARTICLE
|
doi:10.20944/preprints202309.0619.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
acute lymphoblastic leukemia; imatinib; dasatinib: nilotinib; ponatinib; blinatumomab; reducedintensity chemotherapy; chemotherapy-free; progression-free
Online: 11 September 2023 (04:05:57 CEST)